Abstract OBJECTIVE: This study examined the levels of interleukin (IL)-1β, IL-6, IL-8 and tumor necrosis factor alpha (TNF-α) in peripheral blood of premature infants with chronic lung disease (CLD) in order to investigate the possible role of immunologic factors in CLD. METHODS: Twenty-six premature infants who had been admitted to the neonatal intensive care unit for 28 days were classified into CLD (n=14) and non-CLD (control, n=12) groups. IL-1β, IL-6, IL-8 and TNF-α concentrations in peripheral blood were measured by multiplex technique (Bio-plex). RESULTS: There were no significant differences in peripheral blood levels of IL-1β, IL-6, IL-8 and TNF-α between the two groups. CONCLUSIONS: There are no significant changes in peripheral blood levels of IL-1β, IL-6, IL-8 and TNF-α in premature infants with CLD on the non-acute phase. Immunologic factors might not play a key role in CLD on the phase.［Chin J Contemp Pediatr, 2010, 12 (11):855-857］
LUO Ying,TANG Li-Jun,HUANG Wei-Min. Levels of cytokines in peripheral blood of premature infants with chronic lung disease[J]. 中国当代儿科杂志, 2010, 12(11): 855-857.
LUO Ying,TANG Li-Jun,HUANG Wei-Min. Levels of cytokines in peripheral blood of premature infants with chronic lung disease[J]. CJCP, 2010, 12(11): 855-857.
［1］Bose CL, Dammann CE, Laughon MM. Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate［J］. Arch Dis Child Fetal Neonatal Ed, 2008, 93(6): F455-F461.
［2］Merritt TA, Deming DD, Boynton BR. The 'new' bronchopulmonary dysplasia: challenges and commentary［J］. Semin Fetal Neonatal Med, 2009, 14(6):345-357.
［3］Cayabyab RG, Jones CA, Kwong KY, Hendershott C, Lecart C, Minoo P, et al. Interleukin-1beta in the bronchoalveolar lavage fluid of premature neonates: a marker for maternal chorioamnionitis and predictor of adverse neonatal outcome［J］. Matern Fetal Neonatal Med, 2003, 14(3): 205-211.
［5］Truog WE, Ballard PL, Norberg M, Golombek S, Savani RC, Merrill JD, et al. Inflammatory markers and mediators in tracheal fluid of premature infants treated with inhaled nitric oxide［J］. Pediatrics, 2007, 119(4): 670-678.
［6］De Dooy J, Ieven M, Stevens W, De Clerck L, Mahieu L. High levels of CXCL8 in tracheal aspirate samples taken at birth are associated with adverse respiratory outcome only in preterm infants younger than 28 weeks gestation［J］. Pediatr Pulmonol, 2007, 42(3): 193-203.
［7］Vento G, Matassa PG, Ameglio F, Capoluongo E, Zecca E, Tortorolo L, et al. HFOV in premature neonates:effects on pulmonary mechanics and epithelial lining fluid cytokines. A randomized controlled trial［J］. Intensive Care Med, 2005, 31(3): 463-470.
［8］Von der Hardt K, Kandler MA, Fink L, Schoof E, D-tsch J, Brandenstein O, et al. High frequency oscillatory ventilation suppresses inflammatory response in lung tissue and microdissected alveolar macrophages in surfactant depleted piglets［J］. Pediatr Res, 2004, 55(2): 339-346.
［9］Jónsson B, Tullus K, Brauner A, Lu Y, Noack G. Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants［J］. Arch Dis Child Fetal Neonatal Ed, 1997, 77(3): 198-201.
［10］Kazzi SN, Romero R, McLaughlin K, Ager J, Janisse J. Serial changes in levels of IL6 and IL-1beta in premature infants at risk for bronchopulmonary dysplasia［J］. Pediatr Pulmonol, 2001, 31(3): 220-226.
［12］Deakins KM.Bronchopulmonary dysplasia［J］. Respir Care, 2009, 54(9): 1252-1262.
［13］Patterson AM, Taciak V, Lovchik J, Fox RE, Campbell AB, Viscardi RM. Ureaplasma urealyticum respiratory tract clonization is associated with an increase in interleukin 1-beta and tumor necrosis factor alpha relative to interleukin 6 in tracheal aspirates of preterm infants［J］. Pediatr Infect Dis J, 1998, 17(4): 321-328.
［14］An H, Nishimaki S, Ohyama M, Haruki A, Naruto T, Kobayashi N, et al. Interleukin-6, interleukin-8, and soluble tumor necrosis factor receptorⅠ in the cord blood as predictors of chronic lung disease in premature infants［J］. Am J Obsret Gynecol, 2004, 191(5): 1649-1654.
［15］Mahieu LM, De Dooy JJ, leven MM, Bridts CH, Stevens WJ. Increased levels of tumor necrosis factor-alpha and decreased levels of interleukin-12 p70 in tracheal aspirates, within 2 hrs after birth, are associated with mortality among ventilated preterm infants［J］. Pediatr Crit Cara Med, 2005, 6(6): 682-689.
［16］Tullus K, Noack GW, Burman LG, Nilsson R, Wretlind B, Brauner A. Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchpulmonary dysplasia［J］.Eur J Pediatr, 1996, 155(2): 112-116.
［18］Capoluongo E, Vento G, Santonocito C, Matassa PG, Vaccarella C, Giardina B, et al. Comparison of serum levels of seven cytokines in premature newborns undergoing different ventilatory procedures: high frequency oscillatory ventilation or synchronized intermittent mandatory ventilation［J］. Eur Cytokine Netw, 2005, 16 (3): 199-205.
［19］Thompson A, Bhandari V. Pulmonary biomarkers of bronchopulmonary dysplasia［J］. Biomark Insights, 2008, 3: 361-373.
